CITIUS PHARMACEUTICALS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.5837 USD | -8.54% |
|
-4.15% | -22.84% |
Chart calendar Citius Pharmaceuticals, Inc.
800f.w3ScGOayOjhnyU2CMG2ctClXkqvx0S7TqjHApFEVewo.okDmYraBDF4dkwTNRVzK-HYaquC1hVa_512yyw5yVkjyINJrn59tbguDfQ~da877730731e2f636ed8064b582c697c
Upcoming events on Citius Pharmaceuticals, Inc.
Past events on Citius Pharmaceuticals, Inc.
| 13/06/2024 14:15 | Sidoti Small Cap Conference |
| 03/06/2024 13:30 | Mino-Lok Phase 3 Trial Results Call |
| 20/05/2024 20:30 | H.C. Wainwright BioConnect Investor Conference |
| 14/05/2024 | EF Hutton Investor Conference |
| 14/05/2024 21:05 | Q2 2024 Earnings Release |
| 17/04/2024 15:30 | Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference |
| 09/04/2024 20:30 | LD Micro Invitational Conference |
| 13/03/2024 17:45 | Sidoti Small Cap Conference |
| 12/03/2024 12:00 | Annual General Meeting |
| 27/02/2024 14:45 | BIO CEO & Investor Conference |
| 14/02/2024 21:30 | Q1 2024 Earnings Release |
| 02/01/2024 13:30 | Q4 2023 Earnings Release |
| 04/12/2023 05:00 | Noble Capital Markets Emerging Growth Equity Conference |
| 28/11/2023 | GCFF Virtual Healthcare Conference |
| 15/11/2023 16:30 | Sidoti Microcap Virtual Conference |
| 19/10/2023 19:30 | ThinkEquity Conference |
| 12/10/2023 18:30 | Dawson James Small Cap Growth Conference |
| 20/09/2023 19:30 | Sidoti Small Cap Conference |
| 11/09/2023 19:00 | H.C. Wainwright Global Investment Conference |
| 14/08/2023 21:15 | Q3 2023 Earnings Release |
Annual results
| Fiscal Period | September | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -15,6 -15,9 1.9% | -17,7 -18,8 5.79% | -23,5 -24,9 5.54% | -33,3 -34,5 3.48% | -36,7 -35,6 -3.16% | -38,6 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | -23,1 -24,7 6.57% | -33,1 -34,4 3.8% | -32,0 -31,1 -2.94% | -37,0 |
|
Net income Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | -24,5 -24,7 0.69% | -33,6 -34,4 2.13% | -33,7 -31,6 -6.53% | -37,2 |
|
EPS USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | -0,23 -0,23 0% | -0,23 -0,24 4.17% | -0,22 -0,21 -4.76% | -0,22 |
| Announcement Date | 16/12/19 | 16/12/20 | 15/12/21 | 22/12/22 | 29/12/23 | - |
Quarterly results
| Fiscal Period | September | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 10,6 | 11,0 | 11,9 |
|
EBIT Million USD | Released Forecast Spread | -7,59 -10,5 27.89% | -8,92 -8,99 0.77% | -7,55 -8,75 13.74% | -10,7 -7,54 -41.8% | -8,67 -10,7 18.8% | -10,1 -8,95 -13.13% | -11,0 -8,31 -32% | -9,49 | -9,81 | |||||
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -7,56 -10,5 28.17% | -8,86 -8,99 1.36% | -7,41 -8,72 14.99% | -10,4 -7,49 -38.56% | -8,34 -10,6 21.66% | -9,80 -8,89 -10.28% | -8,40 -8,31 -1.08% | -9,49 | -9,81 | |||||
|
Net income Million USD | Released Forecast Spread | -7,56 -10,5 28.17% | -8,86 -8,99 1.36% | -7,99 -8,72 8.38% | -3,59 | -10,5 -7,54 -39.55% | -8,48 -10,7 20.68% | -11,1 -8,97 -23.76% | -8,54 -8,31 -2.81% | -9,49 | -9,81 | ||||
|
EPS USD | Released Forecast Spread | -0,05 -0,07 28.57% | -0,06 -0,06 0% | -0,05 -0,06 16.67% | -0,02 | -0,07 -0,05 -40% | -0,06 -0,07 14.29% | -0,07 -0,06 -16.67% | -0,06 | -0,05 -0,06 9.09% | -0,06 | -0,06 | |||
| Announcement Date | 12/05/22 | 11/08/22 | 22/12/22 | 10/02/23 | 12/05/23 | 14/08/23 | 29/12/23 | 14/02/24 | 14/05/24 | - | - | - | - | - |
| 15/07/2024 06:45 | ADDLIFE AB: Q2 2024 Earnings Release |
| 21/07/2024 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release |
| 23/07/2024 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
| 23/07/2024 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
| 23/07/2024 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
| 23/07/2024 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected) |
| 24/07/2024 | LONZA GROUP AG: Q2 2024 Earnings Release |
| 25/07/2024 06:00 | BACHEM HOLDING AG: Q2 2024 Earnings Release |
| 25/07/2024 | PHARVARIS N.V.: Q2 2024 Earnings Release (Projected) |
| 26/07/2024 06:00 | BB BIOTECH AG: Q2 2024 Earnings Release |
Past sector events for Citius Pharmaceuticals, Inc.
| 07/06/2024 07:57 | POLARIS GROUP: May 2024 Sales and Revenue Release |
| 29/05/2024 21:01 | IMMUNOVANT, INC.: Q4 2024 Earnings Release |
| 23/05/2024 12:00 | CUREVAC N.V.: Q1 2024 Earnings Release |
| 22/05/2024 06:00 | EVOTEC SE: Q1 2024 Earnings Release |
| 21/05/2024 22:14 | ALVOTECH: Q1 2024 Earnings Release |
| 21/05/2024 12:00 | EXSCIENTIA PLC: Q1 2024 Earnings Release |
| 17/05/2024 07:00 | BIOARCTIC AB: Q1 2024 Earnings Release |
| 15/05/2024 21:05 | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 15/05/2024 12:00 | PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 14/05/2024 | GNI GROUP LTD.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- CTXR Stock
- Calendar Citius Pharmaceuticals, Inc.
